Wave Life Sciences
183 hedge funds and large institutions have $1.59B invested in Wave Life Sciences in 2024 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 76 increasing their positions, 38 reducing their positions, and 24 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 38
92% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 24
73% more call options, than puts
Call options by funds: $9.23M | Put options by funds: $5.33M
61% more capital invested
Capital invested by funds: $986M → $1.59B (+$605M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
13% more funds holding
Funds holding: 162 → 183 (+21)
9.58% less ownership
Funds ownership: 93.91% → 84.33% (-9.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$27.5M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$26.3M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$22.2M |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$13.3M |
| 5 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$11.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$26.3M |
| 2 |
MC
Maverick Capital
Dallas,
Texas
|
-$23.8M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$12.5M |
| 4 |
TPC
Takeda Pharmaceutical Company
Tokyo,
Japan
|
-$11M |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
-$9.08M |
WVE Hedge Fund Activity: Q4 2024 in Review
183 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q4 2024, worth a combined $1.59B — up 61% from $986M a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new WVE positions and 24 closed out — a net gain of 22 holders — while 76 added to existing stakes and 38 trimmed.
The largest buyer was BlackRock, adding an estimated $27.5M. The largest seller was Siren LLC, cutting an estimated $26.3M.
- 183 institutional investors held Wave Life Sciences (WVE) as of Q4 2024, up from 162 in Q3 2024.
- Funds reported $1.59B of Wave Life Sciences stock for Q4 2024, up 61% quarter-over-quarter.
- 46 funds opened new Wave Life Sciences positions in Q4 2024 and 24 closed out, a net change of +22 holders.
- The largest Wave Life Sciences buyer in Q4 2024 was BlackRock, an estimated $27.5M added.
- The largest Wave Life Sciences seller in Q4 2024 was Siren LLC, an estimated $26.3M sold.
Based on aggregated 13F filings for Q4 2024.